Swift Biosciences, pioneers in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) and SPT Labtech, providers of liquid handling solutions announce a collaboration to leverage Swift’s efficient NGS library preparation kits on SPT Labtech’s highly efficient mosquito® genomics and dragonfly® discovery. The partnership will expand the portfolio of library prep […]

License to Nobel prize winning CRISPR technology supports internal research and development DUBLIN, Ireland, 03 March 2021: ERS Genomics Limited, which was formed to provide broad access to foundational CRISPR/Cas9 intellectual property today announced the signing of a license agreement with Otsuka Pharmaceutical Co. Ltd. (Otsuka). The license grants Otsuka access to CRISPR/Cas9 genome editing technology […]

SAN DIEGO and SANTA CLARA, CALIF. –  Biosero, Inc. and Celltrio, Inc. will integrate Biosero’s Green Button Go™ Automation Scheduling Software with Celltrio’s innovative RoboCell™ Automation Platform to accelerate cell line culturing and harvesting processes, including cryogenic storage, into a highly flexible and modular end-to-end system. “Combining the Green Button Go™ scheduling software platform with our robotic cell line development platform […]

Strategic collaboration combines germline genetic testing, next-generation tumor sequencing and world-class testing capabilities to elevate global precision oncology care SALT LAKE CITY — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a new strategic precision oncology collaboration with Intermountain Precision Genomics, a service of Intermountain Healthcare. This collaboration […]

Mobile platform intended to produce >1,000s of ready-to-use doses at the site of need in under 3 days Project leverages GE’s expertise regarding synthetic method for producing industrial amounts of DNA GE’s DNA-based approach could be compatible with new, recently approved RNA-based COVID-19 vaccines NISKAYUNA, NY – March 2, 2021 – Aiming to enable vaccine production […]

Astronomy and Pathology (AstroPath™) come together for the first time to discover and clinically validate new spatial phenotypic signatures using multiplex immunofluorescence. Marlborough, MA —  Akoya Biosciences, Inc., The Spatial Biology Company®, today announced a collaboration with the Bloomberg-Kimmel Institute for Cancer Immunotherapy (BKI) and the Bloomberg Center for Physics and Astronomy at the Johns […]

SOUTH SAN FRANCISCO, Calif. & BOULDER, Colo. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker Genomics today announced a broad partnership to enable innovative research across a wide range of high throughput sequencing applications including oncology and tumor […]

SOUTH SAN FRANCISCO, Calif. and PARIS — DNA Script, a leading pioneer in enabling DNA synthesis on demand, today announced that the company has been selected by GE Research to join a collaboration to develop a rapid response, mobile medical manufacturing platform to enable on-demand production of nucleic acid-based vaccines and therapies. The $41-million, five-year project was awarded as […]

FRANKFURT AM MAIN, GERMANY — Vivlion GmbH today announced the execution of a non-exclusive license agreement with the Broad Institute of MIT and Harvard. The agreement provides Vivlion with access to CRISPR/Cas9 intellectual property from the Broad Institute and its partners. Vivlion is a Frankfurt-based startup company providing next generation CRISPR/Cas gRNA libraries and screening services for the […]

Malvern Panalytical to support Leukocare in its formulation development projects on Covid-19 vaccine stabilization Combining profound knowhow and analytical expertise to improve stability of Covid-19 vaccines Martinsried/Munich, Germany and Malvern, United Kingdom, March 01, 2021 Leukocare AG and Malvern Panalytical Ltd today announced an exciting collaboration whichb will improve the availability of vaccines for COVID-19. […]